Cargando…
Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies
Multiple myeloma is a hematological cancer type. For its treatment, Bortezomib has been widely used. However, drug resistance to this effective chemotherapeutic has been developed for various reasons. 2D cell cultures and animal models have failed to understand the MM disease and Bortezomib resistan...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864669/ https://www.ncbi.nlm.nih.gov/pubmed/36678608 http://dx.doi.org/10.3390/ph16010111 |